Dr McQuaid Clinical & Medical Research Limited
Company Summary
Dr McQuaid Clinical & Medical Research Limited was set up on Monday the 14th of September 2020. Their current partial address is Dublin, and the company status is Struck Off. The company's current director has been the director of 0 other Irish companies. Dr McQuaid Clinical & Medical Research Limited has 1 shareholder.
| Company Name: | Dr McQuaid Clinical & Medical Research Limited | |
| Company Status: | STRUCK OFF | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| Company Address: | 134 Glenageary Avenue, Glenageary, Co. Dublin, Dublin | |
| Key Executive: | Ms McQuaid | |
| Company Size: | Log-In To View | |
Key Contact Profile
Ms McQuaid is a Company Director of Dr McQuaid Clinical & Medical Research Limited since 2020
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
Latest Updates
The latest documents filed with the Companies Registration Office for Dr McQuaid Clinical & Medical Research Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form H15: Application for Voluntary strike-off | 26/01/2026 | Join Up | ||
| Letter Of No Objection | 26/01/2026 | Join Up | ||
| Advertisement | 26/01/2026 | Join Up | ||
| Form B1C - Annual Return General | 14/03/2025 | 04/11/2025 | Join Up | |
| FINANCIAL STATEMENT | 14/03/2025 | 04/11/2025 | Join Up | |
| THIS COMPANY HAS 11 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
Credit Report
View the Latest Credit Report and Credit Limit on Dr McQuaid Clinical & Medical Research Limited.
| Company Status: | Struck Off | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| Latest Credit Movement: |  | |
| Date of Last Movement: | 12/05/2026 | |
| Latest Accounts Filed: | 04/11/2025 | |
| Report Based on Accounts: | 31/12/2024 | |
| Next Set of Accounts Due: | 14/03/2026 | |
| Overdue: | No | |
| Credit Score: | Join-Up to View | |
Full Credit Rating
To View the latest Credit Rating or Credit Limit on Dr McQuaid Clinical & Medical Research Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Directors & Owners
Satisfy due diligence requirements on Dr McQuaid Clinical & Medical Research Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Dr McQuaid Clinical & Medical Research Limited and Anti-Money Laundering checks (AML checks) on Dr McQuaid Clinical & Medical Research Limited
Directors details are available to logged in users.
Ownership Structure
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Compliance
Log-in now to run Due Diligence checks and Compliance checks on Dr McQuaid Clinical & Medical Research Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
Ask Us A Question...?
More people choose Vision-net over any other search service... ask us why?
AML Compliance: What Businesses Need to Be Ready For
12/05/2026
AML Compliance: What Businesses Need to Be Ready For
Risk Audit: Clearer Insight Across Your Portfolio
01/05/2026
In today's trading environment, risk rarely presents itself in a single moment. Credit profiles shift, financial resilience weakens, and company status changes can occur quietly in the background.
ESG Insight for Smarter Business Decisions
27/04/2026
As we recently marked Earth Day 2026, the focus on sustainability has highlighted a simple reality: ESG is now a practical part of everyday business decision-making.
Q1 Insights: Shifts in Leadership and Credit Dynamics
17/04/2026
While strong new business formation set a positive tone for the opening quarter of 2026, the wider financial and governance picture reveals a more nuanced environment.